Learn more about MDS at http://www.YouAndMDS.com
Prof. Valeria Santini, an expert on MDS from the University of Florence, explains that mutationdriven treatments aim to affect MDS progression by targeting chromosomal alterations or gene mutations present in MDS. She also describes how the presence of additional mutations can affect the goal of slowing progression.